TABLE 5.

Comparison of serial IMMY GM ASR and MVista EIA results for four patients

Serial test	Quantitative results (ng/ml) (qualitative results)a
	Patient 1b		Patient 2c		Patient 3d		Patient 4e
	IMMY ASR	MVista EIA	IMMY ASR	MVista EIA	IMMY ASR	MVista EIA	IMMY ASR	MVista EIA
1	0.24 (Ind.)	0.56 (Pos.)	9.66 (Pos.)	15.94 (Pos.)	1.45 (Pos.)	7.49 (Pos.)	0.6 (Pos.)	1.31 (Pos.)
2	0 (Neg.)	ND	11.1 (Pos.)	14.03 (Pos.)	1.70 (Pos.)	10.2 (Pos.)	0.6 (Pos.)	1.35 (Pos.)
3	0 (Neg.)	ND	4.51 (Pos.)	7.48 (Pos.)	—	—	—	—

^aInd., indeterminate; Pos., positive; Neg. negative; ND, not detected; —, testing not performed.

^bPatient 1 was a 69-year-old man who was diagnosed with disseminated histoplasmosis in April 2013 and remained on itraconazole therapy; 3 months elapsed between serial tests 1 and 2, and 2 months elapsed between serial tests 2 and 3.

^cPatient 2 was a 62-year-old man who was diagnosed with disseminated histoplasmosis in October 2012 and remained on itraconazole therapy; 2 months elapsed between serial tests 1 and 2, and 2.5 months elapsed between serial tests 2 and 3.

^dPatient 3 was a 22-year-old man who was diagnosed with disseminated histoplasmosis in December 2011 and remained on voriconazole therapy; 3 months elapsed between serial tests 1 and 2.

^ePatient 4 was a 65-year-old man who was diagnosed with disseminated histoplasmosis in January 2013 and remained on itraconazole therapy; 2.5 months elapsed between serial tests 1 and 2.